Published September 2007 | Version v1
Journal article

Heart failure and 1231-M.I.B.G. scintigraphy: comeback

  • 1. Centre Hospitalier Universitaire Cote de Nacre, Service de Medecine Nucleaire, 14 - Caen (France)
  • 2. Centre de Lutte Contre le Cancer Henri-Becquerel, Service de Medecine Nucleaire, 76 - Rouen (France)
  • 3. Centre Hospitalier Universitaire Cote de Nacre, Service de Cardiologie, 14 - Caen (France)
  • 4. Hopital de Trouville, Service de Readaptation Cardiaque, 14 - Trouville (France)

Description

Congestive heart failure is a often associated with an impairment of sympathetic nervous system, i.e., global hyperactivity and regional impairment of adrenergic system. Cardiac 123I-meta-iodo-benzyl-guanidine (M.I.B.G.) scintigraphy is a radionuclide technique which can explore the presynaptic adrenergic function. Cardiac fixation of M.I.B.G. is decreased in congestive heart failure, reflecting a reduction of norepinephrine uptake by the myocardial presynaptic ending nerves. The impairment of presynaptic function is early and actually involved in the pathogenesis of cardiac failure. Cardiac M.I.B.G. scintigraphy is a useful tool to explore the myocardial adrenergic stores in patients with congestive heart failure. (authors)

Availability note (English)

Available from doi:

Additional details

Additional titles

Original title (French)
Scintigraphie cardiaque a la 1231-metaiodobenzylguanidine et cardiomyopathies: le retour

Identifiers

Publishing Information

Journal Title
Medecine Nucleaire. Imagerie Fonctionnelle et Metabolique
Journal Volume
31
Journal Issue
no.9
Journal Page Range
p. 464-472
ISSN
0928-1258
CODEN
MNIMEX

Conference

Title
45. colloquium of nuclear medicine in French speaking
Original Conference Title
45. colloque de medecine nucleaire de langue francaise
Dates
16-19 Sep 2007
Place
Bordeaux (France)

Optional Information

Notes
43 refs.; 1 fig.; 3 charts.